A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice

References

• Bajgar, J. (2004). Organophosphate/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Bajgar, J., Fusek, J., Kuca, K., Bartosova, L., Jun, D. (2007). Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini-Rev Med Chem 7:461–466.
   PubMed Web of Science ®Google Scholar
• Cabal, J., Bajgar, J. (1999). Tabun —reappearance 50 years later [in Czech]. Chem Listy 93:27–31.
   Web of Science ®Google Scholar
• Clement, J. G., Hansen, A. S., Boulet, C. A. (1999). Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66:216–219.
   Web of Science ®Google Scholar
• Dawson, R. M. (1994). Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317–331.
   PubMed Web of Science ®Google Scholar
• de Jong L. P. A., Benschop, H. P., van den Berg G. R., Wolring, G. Z., de Korte D. C. (1981). Reactivation of tabun-inhibited acetylcholinesterase by 1-(hetero)arylmethyl-pyridinium oximes. Eur J Med Chem 16:257–262.
   Web of Science ®Google Scholar
• Ekström, F., Akfur, C., Tunemalm, A. K., Lundberg, S. (2006). Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 45:74–81.
   PubMed Web of Science ®Google Scholar
• Ellman, G. L., Courtney, D. K., Andres, V., Jr., Feartherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–93.
   PubMed Web of Science ®Google Scholar
• Jokanovic, M., Maksimovic, M. (1995). A comparison of trimedoxime, obidoxime, pralidoxime, and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch Toxicol 70:119–123.
   PubMed Web of Science ®Google Scholar
• Kassa, J. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Cabal, J. (1999a). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111–118.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Cabal, J. (1999b). A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexylmethylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41–45.
   PubMedGoogle Scholar
• Kassa, J., Kuca, K., Bartosova, L., Kunesova, G. (2007). The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267–283.
   Web of Science ®Google Scholar
• Koplovitz, I., Stewart, J. R. (1994). A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol Lett 70:169–179.
   Web of Science ®Google Scholar
• Lorke, D. E., Kalasz, H., Petroianu, G. A., Tekes, K. (2008). Entry of oximes into the brain. A review. Curr Med Chem 15:743–753.
   PubMed Web of Science ®Google Scholar
• Lotti, M. (2000). Organophosphorus compounds. In:Spencer P. S., Schaumburg H. H. (Eds.), Experimental and clinical neurotoxicology (pp 898–925). New York: Oxford University Press.
   Google Scholar
• Marrs, T. C. (1993). Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2007). Synthesis of the novel series of nonsymmetrical bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 22:425–432.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V.,Opletalova, V., et al. (2008a). Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 23:70–76.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Jampilek, J., Dohnal, V., Jun, D., Gunn-Moore, F., Dolezal, M., et al. (2008b). RP-HPLC determination of the lipophilicity of bispyridinium reactivators of acetylcholinesterase bearing a but-2-ene connecting linker. Anal Bioanal Chem 391:367–372.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2005). Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enz Inhib Med Chem 20:409–415.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Kucera, J., Jun, D., Dohnal, V., Opletalova, V., Kuca, K. (2008c). Monoquaternary pyridinium salts with modified side chain—synthesis and evaluation on model of tabun- and paraoxon-inhibited acetylcholinestrase. Bioorg Med Chem 16:8218–8223.
   PubMed Web of Science ®Google Scholar
• Petroianu, G. A., Nurulain, S. M., Nagelkerke, N., Shafiullah, M., Kassa, J., Kuca, K. (2007). Five oximes (K-27, K-48, obidoxime, HI-6, and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J Appl Toxicol 27:453–457.
   PubMed Web of Science ®Google Scholar
• Puu, G., Artursson, E., Bucht, G. (1986). Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 35:1505–1510.
   PubMed Web of Science ®Google Scholar
• Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Teute, K., et al. (2003). Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Tallarida, R.., Murray, R. (1987). Manual of pharmacological calculation with computer programs. New York: Springer-Verlag.
   Google Scholar
• Worek, F., Kirchner, T., Bäker, M., Szinicz, L. (1996). Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70:497–503.
   PubMed Web of Science ®Google Scholar
• Worek, F., Widmann, R., Knopff, O., Szinicz, L. (1998). Reactivating potency of obidoxime, pralidoxime, HI-6, and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237–243.
   PubMed Web of Science ®Google Scholar